Text Size

Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00322855
First received: May 5, 2006
Last updated: September 23, 2011
Last verified: October 2008
History of Changes
  Purpose

To review the outcome of patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.


Condition
Sarcoma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by New Mexico Cancer Care Alliance:

Estimated Enrollment: 20
Study Start Date: August 2005
Estimated Study Completion Date: August 2010
Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Chart Review
patients diagnosed with soft tissue sarcoma

Detailed Description:

Chart review of patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005 to determine outcome

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.

Criteria

Inclusion Criteria:

  • Patients diagnosed with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.

Exclusion Criteria:

  • Not Specified
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00322855

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Aroop Mangalik, MD University of New Mexico
  More Information

No publications provided

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00322855     History of Changes
Other Study ID Numbers: INST 0517C
Study First Received: May 5, 2006
Last Updated: September 23, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Sarcoma
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on May 19, 2013